Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS.
Leukemia. 2022 Jul;36(7):1898-1906. doi: 10.1038/s41375-022-01584-3. Epub 2022 May 3.
Leukemia. 2022.
PMID: 35505182
Free PMC article.
Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1.
Trsova I, Hrustincova A, Krejcik Z, Kundrat D, Holoubek A, Staflova K, Janstova L, Vanikova S, Szikszai K, Klema J, Rysavy P, Belickova M, Kaisrlikova M, Vesela J, Cermak J, Jonasova A, Dostal J, Fric J, Musil J, Dostalova Merkerova M.
Trsova I, et al. Among authors: kaisrlikova m.
Mol Oncol. 2023 Dec;17(12):2565-2583. doi: 10.1002/1878-0261.13486. Epub 2023 Jul 17.
Mol Oncol. 2023.
PMID: 37408496
Free PMC article.
Item in Clipboard
Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34+ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients.
Koralkova P, Belickova M, Kundrat D, Dostalova Merkerova M, Krejcik Z, Szikszai K, Kaisrlikova M, Vesela J, Vyhlidalova P, Stetka J, Hlavackova A, Suttnar J, Flodr P, Stritesky J, Jonasova A, Cermak J, Divoky V.
Koralkova P, et al. Among authors: kaisrlikova m.
Cancers (Basel). 2021 Apr 30;13(9):2161. doi: 10.3390/cancers13092161.
Cancers (Basel). 2021.
PMID: 33946220
Free PMC article.
Item in Clipboard
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms.
Kaisrlikova M, Kundrat D, Koralkova P, Trsova I, Lenertova Z, Votavova H, Merkerova MD, Krejcik Z, Vesela J, Vostry M, Simeckova R, Markova MS, Lauermannova M, Jonasova A, Cermak J, Divoky V, Belickova M.
Kaisrlikova M, et al.
Int J Cancer. 2024 May 1;154(9):1652-1668. doi: 10.1002/ijc.34834. Epub 2024 Jan 5.
Int J Cancer. 2024.
PMID: 38180088
Item in Clipboard
Cite
Cite